Zetterberg, H;
Rohrer, JD;
Schott, JM;
(2017)
Chapter 6 - Cerebrospinal fluid in the dementias.
Handbook of Clinical Neurology
, 146
pp. 85-97.
10.1016/B978-0-12-804279-3.00006-X.
![[thumbnail of Rohrer_CH0006_Zetterberg_v1FD- CSF.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Rohrer_CH0006_Zetterberg_v1FD- CSF.pdf - Accepted Version Access restricted to UCL open access staff Download (286kB) |
Abstract
Alzheimer disease, vascular dementia, dementia with Lewy bodies, and frontotemporal dementia are the most common central nervous system disorders that cause progressive neurocognitive dysfunction and ultimately dementia. A number of biomarkers for pathologies reflecting each condition have been developed. Here, we review these and give an overview of the current state of practice and research regarding cerebrospinal fluid biomarkers for these disorders. The chapter discusses both established (most of which are tau- and amyloid β-related) and upcoming biomarkers and details, wherever appropriate, clinical use and differential diagnostics aspects.
Archive Staff Only
 |
View Item |
